16 reports

This year, the wholly owned subsidiary cell pharm launched the filgrastim product Grastrofil.

  • Insulin
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Biocon Limited - Preclinical, 2016
  • Biocon Limited - Pipeline by Indication, 2016
  • Insulin
  • India
  • World
  • Product Initiative
  • Biocon Limited
  • 6.2 RECOMBINANT HORMONES

It has received approval for tbo-filgrastim (XM## filgrastim).

  • Insulin
  • Biocon Limited
  • Hospira, Inc.
  • Mylan Inc.
  • Sandoz Inc.
  • Insulin Resistance - Companies Involved in Therapeutics Development
  • INSULIN RESISTANCE - PIPELINE BY AMGEN INC, H1 2017

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Insulin
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

GRANIX VELCADE LONQUEX Lonquex (lipegfilgrastim) is a long-acting G-CSF that contains the active ingredient lipegfilgrastim, a glycoPEGylated filgrastim molecule.

  • Insulin
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

Filgrastim is very similar to a human protein called granulocyte-colony-stimulating factor (G-CSF).

  • Biosimilar
  • Insulin
  • India
  • United States
  • Biocon Limited

Clinical Development of BiosimilarsThe Biocon-Mylan partnership includes six biosimilar programs (Trastuzumab, Pegfilgrastim, Adalimumab, Bevacizumab, Etanercept and Filgrastim) and three insulin analog programs (Glargine, Lispro and Aspart).

  • Insulin
  • Asia
  • India
  • Market Size
  • Biocon Limited

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Antimalarials
  • In Vitro Diagnostics
  • Insulin
  • Molecular Diagnostic
  • Product Initiative
  • ROLE IN THE BIOSIMILARS INDUSTRY
  • CORPORATE ANALYSIS

HENCE, PEG-FILGRASTIM HAS A DISTINCT ADVANTAGE IN TERMS OF PATIENT SAFETY AGAINST FILGRASTIM.

  • Insulin
  • Europe
  • World
  • Roche Group
  • Sandoz Inc.

FILGRASTIM ##. ##. ##.

  • Insulin
  • Asia
  • Europe
  • World
  • Market Size

Clinical Development of BiosimilarsThe Biocon-Mylan partnership includes six biosimilar programs (Trastuzumab, Pegfilgrastim, Adalimumab, Bevacizumab, Etanercept and Filgrastim) and three insulin analog programs (Glargine, Lispro and Aspart).

  • Insulin
  • Insulin Delivery
  • United States
  • Demand
  • GlobalData's company

Filgrastim, Neulasta, Sandoz LA-EP2006, and TEVA Balugrastim (includes corresponding Graph/ Chart) III-## Vaccines Industry in the US III-## Federal Research & Grants..............

  • Insulin
  • Vaccine
  • Europe
  • World
  • Market Size

QU=NEULASTA+FILGRASTIM& KID=##& T=NEULASTA& F=DRUGS& NEWS=##& PAGE=## ## SOURCE: HTTPS:/ / WWW. CDC. GOV/ H##N##FLU/ VACCINATION/ SYRINGES_QA. HTM ## SMARTJECT® IS A REGISTERED TRADEMARK OF JOHNSON & JOHNSON ## SOURCE: HTTP:/ / PHARMACYSERVICES.

  • Insulin
  • Debiotech S.A.
  • Medtronic, Inc.
  • Roche Group
  • West Pharmaceutical Services, Inc.
  • GLOBAL FORECAST TO 2019

Report Title Published Date ## Biosimilars Market - By Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Trends & Global Fore

  • Insulin
  • Europe
  • World
  • Market Size
  • Novo Nordisk Group

The company offers products such as sevelamer, ciprofloxacin, amitriptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others.

  • Biopharmaceutical
  • Insulin
  • United States
  • Company
  • Product Initiative

The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others.

  • Insulin
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative